DNA Vaccines Market to Reach USD 8.7 Billion by 2033
The global healthcare landscape is undergoing a profound shift, with genetic science reshaping the foundations of vaccine development. Among these innovations, DNA vaccines have emerged as one of the most promising platforms for disease prevention and therapeutic immunology. Combining genetic engineering with immunology, this approach offers speed, stability, and adaptability that traditional...
0 Comments 0 Shares